Gyre Therapeutics (GYRE) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,797.00 |
| Dec 31, 2025 | 90,526.00 |
| Sep 30, 2025 | 182,557.00 |
| Jun 30, 2025 | 105,521.00 |
| Mar 31, 2025 | 4,127.00 |
| Mar 31, 2023 | 11.13 Mn |
| Dec 31, 2022 | 181,089.00 |
| Mar 31, 2022 | -31,240.00 |
| Dec 31, 2021 | 651,961.00 |
| Sep 30, 2021 | 414,298.00 |
| Jun 30, 2021 | 274,999.00 |
| Mar 31, 2021 | 266,498.00 |
| Dec 31, 2020 | 336,866.00 |
| Sep 30, 2020 | 176,131.00 |
| Jun 30, 2020 | -79,088.00 |
| Mar 31, 2020 | 42,022.00 |
| Mar 31, 2018 | -11.11 Mn |
| Dec 31, 2017 | 92,291.00 |
| Sep 30, 2017 | -79,400.00 |
| Jun 30, 2017 | -539,726.00 |
| Mar 31, 2017 | -154,780.00 |
| Dec 31, 2016 | -729,856.00 |
| Sep 30, 2016 | -519,114.00 |
| Jun 30, 2016 | -449,678.00 |
| Mar 31, 2016 | -422,604.00 |
| Dec 31, 2015 | -429,014.00 |
| Sep 30, 2015 | -534,143.00 |
| Jun 30, 2015 | -276,431.00 |